INSIGHTS ON DRUG DEVELOPMENT

• Right From The Start: Smarter Developability For Stronger Formulations

  Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.

• Improving Consumer Safety Through Innovative Science

  Liquid chromatography revolutionizes science with precision. Discover a technology that leads the charge in enhancing HPLC performance for breakthroughs in health, safety, and environmental research.

• Innovating The mAb Characterization Process

  Understanding the characteristics of a molecule's "personality" is crucial for optimizing development and manufacturing. Learn how to overcome the challenges in the characterization process.

• Viral Gene Therapy: Reducing Costs To Improve Patient Access

  Gene therapy is revolutionizing medicine with its potential to cure genetic disorders. As approvals rise, so do concerns about accessibility, with million-dollar price tags limiting patient access.

• Rethinking Design, Cost, And Scalability In Biomanufacturing

  3/24/2026

  Life science teams increasingly need tools that scale, simplify workflows, and reduce operational costs. Examine how emerging instrumentation focuses on usability, performance, and manufacturability.

• Lightning-Link^® Conjugation Kits: Consistent Performance On A Broad Scale

  9/26/2024

  Learn about labeling technology offering a transformative solution through direct antibody labeling without the need for post-conjugation purification, thereby mitigating antibody loss and ensuring reproducible results.

• Easy Automation For Cell-Based Assays

  10/10/2025

  Automated GPCR screening is now faster and more scalable with integrated cell-based assay solutions. Discover how combining high-throughput platforms with flexible assay kits can streamline workflows.

• Mitigating Early Development Risks

  9/11/2024

  Discover how the efficient screening of biologic candidates accelerates the discovery process, reduces costs, and improves the likelihood of commercializing safe and effective drugs.

• Formulation Strategies For Enabling "Undevelopable" Compounds

  4/29/2025

  KinetiSol enhances bioavailability of poorly soluble drugs like Vemurafenib by producing dense amorphous dispersions, outperforming traditional MBP methods in pharmacokinetics and dissolution.